View the content of this email online

ASGCT 2019: meet us in Washington!

Bandeau NL 27 ASGCT 2019
Come and meet us at booth #413. We will be happy to talk with you about your lentiviral production needs, whether your project is at a discovery or clinical stage.

And don't miss our poster presentation about LentiFlash®, our innovative RNA delivery technology ! 


The poster presents:


Gene editing with LentiFlash® in primary cells (Keratinocytes, T cells, muscle)


Efficient RNA delivery with LentiFlash® without affecting cell viability or      ​​proliferation, and preserving the original cell phenotype


Poster session Date/Time: Tuesday Apr 30, 2019 5:00 PM - 6:00 PM (#444)

To schedule a meeting with our team

Click Here
Image nl news congrès ImmunoT

4th Annual Advances in Immuno-Oncology UK Congress

We are happy to announce that our team will be attending the 4th Annual Advances in Immuno-Oncology UK Congress to be held in London, 20 - 21 May 2019.

Read more
Locaux production GMP

Clinical grade lentiviral vectors

Flash Therapeutics opens a GMP facility to produce lentiviral vector batches for customers conducting phase I/II gene therapy clinical trials.

Read more

Follow us

Twitter Flash Therapeutics LinkedIn Flash Therapeutics Youtube Flash Therapeutics Google + Flash Therapeutics
© Flash Therapeutics 2018

Click here to unsuscribe from the mailing list